Literature DB >> 7115204

Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease.

A Kuksis, J J Myher, K Geher, G J Jones, W C Breckenridge, T Feather, D Hewitt, J A Little.   

Abstract

As part of a population survey and a follow-up study of plasma lipid profiles by high temperature gas-liquid chromatography, we have determined the quantities and relative proportions of all major chemical classes and molecular species of lipids of plasma from 1200 subjects at Visit 2 of the Toronto-McMaster Lipid Research Clinic Prevalence Study. We have compared these values between our 24 subjects with ischemic vascular disease and 73 control subjects matched for age, sex, and plasma total cholesterol and triacylglycerols. The phosphatidylcholine/free cholesterol ratio showed the highest association with ischemic vascular disease of any of over 10 other lipid parameters and all the common risk indicators except high density lipoprotein cholesterol. The phosphatidylcholine/free cholesterol ratio had a relative risk ratio of 20/4 (95% confidence limits, 15/9, 23/1) and high density lipoprotein cholesterol, a risk ratio of 23/1 (95% confidence limits, 24/0, 19/5) for ischemic vascular disease. The average ratio of phosphatidylcholine/free cholesterol for the ischemic vascular disease group was 1.36 and for the controls 1.51, the population average being 1.50. Plasma high density lipoprotein cholesterol had a significant correlation (R = 0.15) with the phosphatidylcholine/free cholesterol ratio in the total population sample. The increased risk for ischemic vascular disease from a lower phosphatidylcholine/free cholesterol ratio may possibly be explained on the basis of decreased fluidity and stability of the lipoproteins due to a relative oversaturation with free cholesterol.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115204     DOI: 10.1161/01.atv.2.4.296

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  9 in total

Review 1.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

Review 2.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

3.  Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

Authors:  S Lahdenperä; M Syvänne; J Kahri; M R Taskinen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin.

Authors:  Raul D Santos; Ana P M Chacra; Aleksandra Morikawa; Carmen C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

5.  Disturbed flow induces systemic changes in metabolites in mouse plasma: a metabolomics study using ApoE⁻/⁻ mice with partial carotid ligation.

Authors:  Young-Mi Go; Chan Woo Kim; Douglas I Walker; Dong Won Kang; Sandeep Kumar; Michael Orr; Karan Uppal; Arshed A Quyyumi; Hanjoong Jo; Dean P Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-05       Impact factor: 3.619

6.  Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension.

Authors:  J D Bagdade; W F Buchanan; T Pollare; H Lithell
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  Lipid composition of platelets from patients with atherosclerosis: effect of purified eicosapentaenoic acid ethyl ester administration.

Authors:  H Kamido; Y Matsuzawa; S Tarui
Journal:  Lipids       Date:  1988-10       Impact factor: 1.880

8.  Effects of postprandial lipemia on plasma cholesterol metabolism.

Authors:  G R Castro; C J Fielding
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

9.  The low-density-lipoprotein pathway of native and chemically modified low-density lipoproteins isolated from plasma incubated in vitro.

Authors:  R Zechner; H Dieplinger; A Roscher; G M Kostner
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.